知镜 Cognispect · 医学文献与研究工作台

Disulfiram Attenuates Adenine-Induced Renal Fibrosis by Modulating Inflammatory and Immunometabolic Responses.

Kin S, Oe Y, Ishigaki S, Fujio I, Miyazaki M, Tanaka T.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026-09-01 · PMID 42750476

文献摘要

Chronic kidney disease (CKD) is partly driven by excessive innate immune activation, which contributes to progressive renal injury and fibrosis. Disulfiram (DSF), an approved treatment for alcohol dependence, has recently emerged as an inhibitor of innate immune responses such as pyroptosis. In this study, we investigated whether DSF attenuates kidney injury in adenine-induced nephropathy and explored the underlying mechanisms. DSF treatment markedly ameliorated kidney injury in adenine-induced nephropathy, accompanied by suppression of inflammatory cell infiltration and inflammasome- and pyroptosis-related markers. RNA sequencing revealed restoration of disrupted fatty acid metabolism in the kidneys following DSF treatment. Furthermore, DSF alleviated DNA damage, cellular senescence, and fibrosis. Importantly, activation of gasdermin D, a central executor of pyroptosis, was closely associated with disease severity in human CKD biopsy samples, supporting the clinical relevance of this pathway. Collectively, these findings suggest a potential role for DSF in modulating inflammatory and immunometabolic pathways in CKD.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。